Depression at time of treatment planning appeared to be as important a predictor of two-year survival as traditional clinical prognostic indicators.
Systemic bevacizumab appears to have significant promise and a low complication profile for the most treatment- resistant and aggressive forms of papillomatosis.
Results suggest that adenoidectomy with electrocautery is significantly less expensive than microdebrider and coblator, with no differences in complication rates.
Eustachian tube dysfunction-related symptom improvement due to surgery of the anterior half of the inferior turbinate was found to be equal to placebo.
PITA is a safe procedure that offers comparable disease control for children suffering from obstructive sleep apnea.
Recurrent respiratory papillomatosis is incurable with current treatment modalities, but adjuvant therapies should be used when surgery cannot control the disease.
There is inadequate evidence to develop a standardized protocol for optimal anticoagulation therapy in patients undergoing free flap reconstruction of the head and neck.
Patients with glottic insufficiency and dyspnea prior to intervention had a significant reduction in dyspnea following treatment.